Invasive Breast Carcinoma Recruiting Phase 2 Trials for Trastuzumab (DB00072)

Also known as: Invasive carcinoma of breast / Breast cancer invasive NOS

IndicationStatusPhase
DBCOND0031787 (Invasive Breast Carcinoma)Recruiting2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT01750073Paclitaxel and Cyclophosphamide With or Without Trastuzumab Before Surgery in Treating Patients With Previously Untreated Breast CancerTreatment